Search Within

Ana Maria Luisa Molina

Formats
  1. Meeting Abstract (31)
  2. Journal Article (19)
Groups
  1. Department of Medicine (47)
  2. Solid Tumor Oncology Division (45)
  3. Genitourinary Oncology Service (44)
  4. Epidemiology and Biostatistics (21)
  5. Biostatistics Service (20)
  6. Radiology, Department of (16)

More Groups

People
  1. Robert Motzer (38)
  2. Sujata Patil (19)
  3. Darren Feldman (17)
  4. Martin Voss (11)
  5. Michelle Ginsberg (8)
  6. Xiaoyu Jia (8)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (4)
  4. 2015 (5)
  5. 2014 (6)
  6. 2013 (8)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Clinical Genitourinary Cancer (3)
  3. Annals of Oncology (2)
  4. Blood (2)
  5. Cancer Chemotherapy and Pharmacology (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier Inc. (6)
  3. Springer (4)
  4. Oxford University Press (3)
  5. American Association for Cancer Research (2)
  6. American Society of Hematology (2)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical and genomic alternations predictive of response to sunitinib in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Motzer, R. J.; Hoetker, A.; Akin, O.; Molina, A. M.; Gold, T. M.; Patil, S.; Janakiraman, M.; Gowrishankar, B.; Houldsworth, J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metastasis-associated mutations in clear cell renal cell carcinoma
    Meeting Abstract

    Gowrishankar, B.; Janakiraman, M.; Lee, C. H.; Thodima, V. J.; Molina, A. M.; Patel, P. H.; Gold, T. M.; Motzer, R. J.; Chaganti, R. S. K.; Kamalakaran, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • First-in-human multicenter phase i study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70
    Journal Article

    Owonikoko, T. K.; Hussain, A.; Stadler, W. M.; Smith, D. C.; Kluger, H.; Molina, A. M.; Gulati, P.; Shah, A.; Ahlers, C. M.; Cardarelli, P. M.; more...
    Cancer Chemotherapy and Pharmacology (2016)

    Fulltext@MSK | Save
  • A phase II trial of everolimus (E) and bevacizumab (B) in advanced non-clear cell renal cell cancer (ncRCC) to show efficacy in patients (pts) with papillary features
    Meeting Abstract

    Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Redzematovic, A.; Wang, P.; Lee, W.; Patil, S.; Molina, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I studies of anti-ENPP3 antibody drug conjugates (ADCs) in advanced refractory renal cell carcinomas (RRCC)
    Meeting Abstract

    Thompson, J. A.; Motzer, R.; Molina, A. M.; Choueiri, T. K.; Heath, E. I.; Kollmannsberger, C. K.; Redman, B. G.; Sangha, R. S.; Ernst, D. S.; Pili, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II trial of everolimus and bevacizumab in advanced non-clear cell renal cell cancer
    Meeting Abstract

    Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Patil, S.; Molina, A. M.; Hsieh, J.; Motzer, R. J.; Feldman, D. R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Association of genome-wide copy number alterations with metastasis of clear cell renal cell carcinoma
    Meeting Abstract

    Gowrishankar, B.; Thodima, V. J.; Molina, A. M.; Ma, C.; Guttapalli, A.; Gold, T. M.; Motzer, R. J.; Chaganti, R. S. K.; Houldsworth, J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save